Skip to main content
. 2017 Jan 15;8(12):20410–20417. doi: 10.18632/oncotarget.14669

Figure 3.

Figure 3

Meta analysis comparing the secondary outcomes of patients receiving neoadjuvant chemoradiotherapy plus surgery and surgery alone (A: R0 resection; B: progression-free survival).